Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Cash from Financing Activities
Santen Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Cash from Financing Activities
-¥40.5B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-18%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Santen Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-40.5B
JPY
Based on the financial report for Dec 31, 2023, Santen Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -40.5B JPY.
What is Santen Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-18%
Over the last year, the Cash from Financing Activities growth was -122%. The average annual Cash from Financing Activities growth rates for Santen Pharmaceutical Co Ltd have been -42% over the past three years , -21% over the past five years , and -18% over the past ten years .